GSK PLC AdrhedgedGSKHETF
13F holders, Q2 2026 (June 30)2holders +1
1new positions
0sold out
$74.00avg. 13F price*
At the end of Q2 2026, 2 institutions reported holding GSK PLC Adrhedged (GSKH) in their 13F filings, up 1 from Q1 2026. 1 opened new positions and 0 sold out. The largest holders were UBS Group AG ($222) and JPMorgan Chase & Co. ($74).
- Company
- GSK PLC Adrhedged
- CUSIP
- 74016W874
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $222 |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 3 shares bought, net +3 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| UBS Group AG | 0.00% | New | 3 | $222 |
| JPMorgan Chase & Co. | 0.00% | No change | 1 | $74 |
"% of holder's portfolio" is GSKH's weight in each manager's 13F, not the share of GSK PLC Adrhedged the manager owns.